Biomedical (applied/exploratory)

Ended Definitive Contract Awarded Last action

Contract number
00268199409D260942114
Awardee
Awarding agency
Obligated
$1,962,878

Award facts

Contract value 5% obligated
  • $41,481,321.02 Current, with exercised options
  • $42,304,985.02 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 21 offers
Pricing
Cost No Fee
Place of performance
Oakland, CA 94612, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 29 -$45,197
Other Administrative Action 28 $0
Other Administrative Action 27 $0
Funding Only Action 26 · WHI (9-8470187) $115,000
Other Administrative Action 25 $0
Funding Only Action 24 · Follow on to clinical trial $208,818
Funding Only Action 23 $203,014
Other Administrative Action 22 $0
Other Administrative Action 21 $0
Other Administrative Action 20 $0
Additional Work (new agreement, FAR part 6 applies) 19 $806,243
Funding Only Action 18 $675,000
Original award $0
Show all 13

About this award

Written by GovTribe AI ·

This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract has a ceiling value of $42,304,985.02 and is a definitive contract with a cost-no-fee pricing type. The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation.

Kaiser Permanente is a large, non-profit healthcare provider and research organization that leverages its extensive patient population and data to conduct clinical trials, epidemiological studies, and health services research for federal agencies. This contract supports public health initiatives such as vaccine safety surveillance, evaluation of COVID-19 and influenza vaccine effectiveness, and studies on the long-term effects of SARS-CoV-2 infection during pregnancy. Kaiser Permanente also holds several significant indefinite delivery vehicles (IDVs) with the CDC and NIH to facilitate ongoing federal research, including the $86 million Clinical Immunization Safety Assessment (CISA) program and the $149 million Vaccine Safety Datalink program.

Quick answers

Who was awarded contract 00268199409D260942114?

00268199409D260942114 was awarded to Kaiser Foundation Hospitals by National Heart Lung and Blood Institute (National Institutes of Health) on June 25, 2004.

How much is contract 00268199409D260942114 worth?

The government has obligated $1,962,878 on 00268199409D260942114. Its current value, with exercised options, is $41,481,321. Its potential value, with all options, is $42,304,985.

Was contract 00268199409D260942114 competed?

The extent of competition for 00268199409D260942114 was full and open competition. The government received 21 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login